← FDA DRUG APPROVALS

FDA NDA · NDA016834

LITHIUM CARBONATE

Sponsor: PFIZER

APPLICATION
NDA016834
TYPE
NDA
ORIGINAL APPROVAL
1970-04-06
LATEST ACTION
1980-03-27
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

LITHIUM CARBONATEDiscontinued
LITHIUM CARBONATE 300MG · TABLET · ORAL

Approval history

1980-03-27Labeling · Supplement 12AP
1978-12-20Labeling · Supplement 11AP
1977-11-11Labeling · Supplement 8AP
1976-07-23Manufacturing (CMC) · Supplement 5 · standardAP
1974-06-24Manufacturing (CMC) · Supplement 3 · standardAP
1970-04-06Type 3 - New Dosage Form · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →